Inovio Receives Authorization from the U.S. FDA To Begin Phase...
PLYMOUTH MEETING, Pennsylvania, Feb. 10, 2020 /PRNewswire-AsiaNet/ -- -- RRP is a rare, potentially fatal orphan disease caused by Human Papillomavirus (HPV) 6 and 11-- Inovio's DNA medicine pipeline includes 15 clinical programs focused on HPV-associated diseases, cancer, and infectious diseases, including the ...
Authors: LATEST ASIANET NEWS RELEASES